相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial
Ahmed Khattab et al.
EuroIntervention (2011)
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
Gregg W. Stone et al.
CIRCULATION (2009)
Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial
Bimmer E. Claessen et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease - A randomized trial
Gregg W. Stone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents
Matthias Pfisterer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Drug therapy - Coronary-artery stents
PW Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Subgroup analyses in therapeutic cardiovascular clinical trials:: Are most of them misleading?
AV Hernández et al.
AMERICAN HEART JOURNAL (2006)
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
ATL Ong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
AJ Carter
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2004)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Oral everolimus inhibits in-stent neointimal growth
A Farb et al.
CIRCULATION (2002)